Healthcare Denmark France Diabetes Chronic

M&A Advisory

Lazard

Full Credential Description

Novo Nordisk. Denmark, France. Announced Date 05/06/2023. Closed Date 11/10/2023. Deal value: $165m. Novo Nordisk enters into exclusive negotiations to acquire a controlling stake in BIOCORP, to be followed by a tender offer on all remaining shares. Industry: Novo Nordisk is a global healthcare company specializing in diabetes care and other chronic diseases.

Back to Search Contact Business